GenomOncology is a precision oncology software company based in Cleveland, Ohio, founded in 2012. The company focuses on transforming complex clinical and molecular data into actionable insights to enhance cancer care. Its mission is to empower healthcare institutions to utilize data-driven decision-making tailored to the specific needs of precision oncology programs.
The core offering is the Precision Oncology Platform (POP), which integrates proprietary algorithms and machine learning to analyze genetic test results and clinical data, providing treatment recommendations and clinical trial matching. Additionally, the GO Pathology Workbench supports germline testing workflows, allowing labs to efficiently validate and report genetic findings. GenomOncology ...
GenomOncology is a precision oncology software company based in Cleveland, Ohio, founded in 2012. The company focuses on transforming complex clinical and molecular data into actionable insights to enhance cancer care. Its mission is to empower healthcare institutions to utilize data-driven decision-making tailored to the specific needs of precision oncology programs.
The core offering is the Precision Oncology Platform (POP), which integrates proprietary algorithms and machine learning to analyze genetic test results and clinical data, providing treatment recommendations and clinical trial matching. Additionally, the GO Pathology Workbench supports germline testing workflows, allowing labs to efficiently validate and report genetic findings. GenomOncology also offers data integration services that combine internal patient data with external annotation sets to generate evidence-based insights. The company primarily serves hospitals, cancer centers, and laboratories looking for scalable tools for genomic data interpretation and therapy matching.
-
Number of Employees:
25-100
-
Annual Revenue:
$1-10 Million